Celgene Corporation announced organizational changes. Jacqualyn Fouse, PhD, has announced her retirement as an officer of the Company effective June 30, 2017 and will not stand for reelection to the Board of Directors at the upcoming Annual Meeting in June. Additionally, effective April 1, 2017: Scott Smith, President, Global Inflammation & Immunology, will be promoted to President and Chief Operating Officer. Terrie Curran will be promoted to President, Global Inflammation & Immunology. Jackie joined Celgene in 2010 as Chief Financial Officer. In 2014, she was appointed President of Celgene's Hematology & Oncology Franchise and in 2016 she was promoted to President and COO. Scott joined Celgene in 2008 and successfully built and launched Celgene's I&I Franchise. Terrie joined Celgene in 2013 as the U.S. Commercial Head of the I&I Franchise and established the framework and built the capabilities for the successful U.S. launch of OTEZLA.